Surgeon choice in the use of postdischarge antibiotics for prophylaxis following mastectomy with and without breast reconstruction.
Publication
, Journal Article
Warren, DK; Nickel, KB; Hostler, CJ; Foy, K; Han, JH; Tolomeo, P; Banks, IR; Fraser, VJ; Olsen, MA; CDC Prevention Epicenter Program
Published in: Infect Control Hosp Epidemiol
April 2021
Multiple guidelines recommend discontinuation of prophylactic antibiotics <24 hours after surgery. In a multicenter, retrospective cohort of 2,954 mastectomy patients ± immediate breast reconstruction, we found that utilization of prophylactic postdischarge antibiotics varied dramatically at the surgeon level among general surgeons and was virtually universal among plastic surgeons.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Infect Control Hosp Epidemiol
DOI
EISSN
1559-6834
Publication Date
April 2021
Volume
42
Issue
4
Start / End Page
467 / 470
Location
United States
Related Subject Headings
- Surgeons
- Retrospective Studies
- Patient Discharge
- Mastectomy
- Mammaplasty
- Humans
- Female
- Epidemiology
- Breast Neoplasms
- Anti-Bacterial Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Warren, D. K., Nickel, K. B., Hostler, C. J., Foy, K., Han, J. H., Tolomeo, P., … CDC Prevention Epicenter Program. (2021). Surgeon choice in the use of postdischarge antibiotics for prophylaxis following mastectomy with and without breast reconstruction. Infect Control Hosp Epidemiol, 42(4), 467–470. https://doi.org/10.1017/ice.2020.462
Warren, David K., Katelin B. Nickel, Christopher J. Hostler, Katherine Foy, Jennifer H. Han, Pam Tolomeo, Ian R. Banks, Victoria J. Fraser, Margaret A. Olsen, and CDC Prevention Epicenter Program. “Surgeon choice in the use of postdischarge antibiotics for prophylaxis following mastectomy with and without breast reconstruction.” Infect Control Hosp Epidemiol 42, no. 4 (April 2021): 467–70. https://doi.org/10.1017/ice.2020.462.
Warren DK, Nickel KB, Hostler CJ, Foy K, Han JH, Tolomeo P, et al. Surgeon choice in the use of postdischarge antibiotics for prophylaxis following mastectomy with and without breast reconstruction. Infect Control Hosp Epidemiol. 2021 Apr;42(4):467–70.
Warren, David K., et al. “Surgeon choice in the use of postdischarge antibiotics for prophylaxis following mastectomy with and without breast reconstruction.” Infect Control Hosp Epidemiol, vol. 42, no. 4, Apr. 2021, pp. 467–70. Pubmed, doi:10.1017/ice.2020.462.
Warren DK, Nickel KB, Hostler CJ, Foy K, Han JH, Tolomeo P, Banks IR, Fraser VJ, Olsen MA, CDC Prevention Epicenter Program. Surgeon choice in the use of postdischarge antibiotics for prophylaxis following mastectomy with and without breast reconstruction. Infect Control Hosp Epidemiol. 2021 Apr;42(4):467–470.
Published In
Infect Control Hosp Epidemiol
DOI
EISSN
1559-6834
Publication Date
April 2021
Volume
42
Issue
4
Start / End Page
467 / 470
Location
United States
Related Subject Headings
- Surgeons
- Retrospective Studies
- Patient Discharge
- Mastectomy
- Mammaplasty
- Humans
- Female
- Epidemiology
- Breast Neoplasms
- Anti-Bacterial Agents